Showing results (591-600 of 1,369) with videos related to

Sort By:
Pageof 137
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancerM Fukuoka, H Niitani, A Suzuki, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1985
[Phase II study of cis-dichlorodiammineplatinum (II) for non-small cell lung cancer]M Fukuoka, K Furuse, M Takada, et al.
Cancer|April 15, 1990
Combination chemotherapy with or without radiation therapy in small cell lung cancer. An analysis of a 5-year follow-upM Fukuoka, N Masuda, K Matsui, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Combination therapy with bestatin in inoperable lung cancer. A randomized trialM Takada, M Fukuoka, S Negoro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycinM Fukuoka, N Masuda, K Furuse, et al.
Cancer|July 15, 1991
A phase I study of chronic daily dosing of oral etoposide in combination with cisplatin for patients with advanced cancerM Fukuoka, N Masuda, S Negoro, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Placebo-controlled double-blind comparative study on the preventive efficacy of mesna against ifosfamide-induced urinary disordersM Fukuoka, S Negoro, N Masuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1988
[Chemotherapy of small cell lung cancer]M Fukuoka, S Negoro, M Takada, et al.
Japanese Journal of Clinical Oncology|September 1, 1986
Alternating non-cross resistant chemotherapy for small cell lung cancerM Fukuoka, M Takada, S Negoro, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1987
[Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer]M Fukuoka, M Takada, T Kamei, et al.
Pageof 137